China Pharma Holdings (CPHI) has released an update to notify the public and investors about the unregistered sales of equity securities.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
A company is set to issue 15 million restricted shares of common stock as part of a technology transfer, dividing them equally among the Transferor and two designees. These shares will be unregistered under U.S. securities laws and issued to non-U.S. persons through an offshore transaction, leveraging Regulation S for exemption from registration requirements.
For further insights into CPHI stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money